Will Febbo | Chief Executive Officer |
Ed Stelmakh | Chief Financial and Operating Officer |
Steve Silvestro | Chief Commercial Officer |
Marion Odence-Ford | General Counsel and Chief Compliance Officer |
Andrew D’Silva | Senior Vice President, Corporate Finance |
Jared Haase | William Blair |
Sean Dodge | RBC Capital Markets |
David Grossman | Stifel |
Joy Zhang | SVB Securities |
Eric Martinuzzi | Lake Street Capital Markets |
Marc Wiesenberger | B. Riley Securities |
Good afternoon, everyone and thank you for joining OptimizeRx’s Third Quarter Fiscal 2022 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, Will Febbo. He is joined by company Chief Financial and Operating Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva. At the conclusion of today’s earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today’s call. I would like to remind everyone that today’s call is being recorded and will be made available for replay via webcast only.